Back

Aspirin has a remaining role in the prevention and treatment of cardiovascular disease: pro.

26 August 2022 (14:00 - 14:20)
Organised by:
Congress Presentation Part of: Great Debate: time to say goodbye to aspirin in cardiovascular disease prevention? Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Carlos Aguiar

Hospital Santa Cruz, Lisbon (Portugal)

2 More presentations in this session

Presentation thumbnail
Aspirin has a remaining role in the prevention and treatment of cardiovascular disease: con.
Professor J. Cleland (Glasgow, GB)
Slides Video
Presentation thumbnail
Time to say goodbye to aspirin in cardiovascular disease prevention? – the final word.
Video

Access the full session

Session thumbnail
Great Debate: time to say goodbye to aspirin in cardiovascular disease prevention?
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Do we really need aspirin?
18 March 2022
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention
27 August 2023
thumbnail
Congress Presentation
Aspirin does not not associate with lower risk of major cardiovascular events or increased risk of bleeding in older individuals undergoing cardiac computed tomography angiography
30 August 2025
thumbnail
Congress Presentation
Aspirin for the primary prevention of major adverse cardiovascular events in patients with elevated lipoprotein(a): a meta-analysis
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources